Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.

Feature | EP Lab | By Maninder Bedi, M.D.

The Future of Remote Monitoring is Streamlining of Cardiac Device Data Management

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

March 17, 2021

Figure 1: Picture of the Emblem S-ICD Subcutaneous Electrode with an arrow showing where separation usually happens (distal to the proximal sense ring).

Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor

Boston Scientific Recalls Emblem S-ICD After 26 Serious Injuries and One Death

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...

February 02, 2021

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.

News | EP Lab

Patient Data From Several Cardiac Devices Streamlined Into One Platform With New Cloud-based Software

February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current ...

February 02, 2021

The most popular story in the month of January 2021 was on a small study that showed the new iPhone 12 can cause ICDs to stop functioning. COVID-19 content continues to rank among the top stories, including an article on the possible long-term cardiac consequences of COVID-19 infection in COVID long-haulers.

Feature | By Dave Fornell, Editor

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

February 01, 2021

A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). iPhone 12 can cause ICDs to stop working

News | Implantable Cardioverter Defibrillator (ICD)

iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...

January 08, 2021

Videos | EP Device Monitoring Systems

VIDEO: Rising Interest in Remote Monitoring of EP Devices in the COVID-19 Era

Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has ...

December 22, 2020

Chest X-ray, posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Feature | Magnetic Resonance Imaging (MRI)

MRI Can Be Safely Performed in Patients With Pacemakers and ICDs

October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR ...

October 27, 2020

Biotronik's closed loop stimulation (CLS) technology helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. #ESC2020

News | EP Lab

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...

September 08, 2020

News | EP Lab

FDA Clears Abbott Gallant ICD and CRT With Bluetooth Connectivity and Continuous Remote Monitoring

July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable ...

July 13, 2020

Videos | HRS

VIDEO: Top New EP Technologies at Heart Rhythm Society 2020

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

May 22, 2020

News | EP Lab

FDA Approves Medtronic Cobalt and Crome ICD Portfolio

May 12, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Cobalt and Crome ...

May 12, 2020

$The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart – for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020$

News | Implantable Cardioverter Defibrillator (ICD)

UNTOUCHED Trial Data Underscores Safety And Efficacy Of Boston Scientific S-ICD System

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

May 08, 2020

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

Feature | Implantable Cardioverter Defibrillator (ICD)

Head-to-head Comparison Shows Subcutaneous ICDs Safer Than Transvenous Defibrillators

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

May 08, 2020

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT) | Valentina Kutyifa M.D., Ph.D.

BIO-LIBRA Study Evaluates Role of Sex and Device Type in Non-ischemic Cardiomyopathy

Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often ...

March 09, 2020

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Feature | EP Lab | Hrishikesh Kadam

The Future of Cardiac Rhythm Management Device Technology

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing ...

November 11, 2019